Carbonic anhydrase inhibitors: Synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties

Journal of Medicinal Chemistry

Volumn 48, Issue 6, 2005, Pages 2121-2125

  Winum, Jean Yves ^a,b   Dogné, Jean Michel ^a,c   Casini, Angela ^a   De Leval, Xavier ^a,c   Montero, Jean Louis ^b   Scozzafava, Andrea ^a   Vullo, Daniela ^a   Innocenti, Alessio ^a   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 CARBOHYDRAZIDO BENZENESULFONAMIDE; 4 CARBOHYDRAZIDO BENZENESULFONAMIDE; ACETAZOLAMIDE; ANTINEOPLASTIC AGENT; BRINZOLAMIDE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONIC ANHYDRASE ISOENZYME IX; DORZOLAMIDE; ETHOXZOLAMIDE; INDISULAM; METHAZOLAMIDE; SULFONAMIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER CONTROL; CONTROLLED STUDY; CYTOSOL; HUMAN; HYPOXIA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN TARGETING;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CARBONIC ANHYDRASE I; CARBONIC ANHYDRASE II; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; CELL MEMBRANE; CYTOSOL; HYDRAZINES; ISOCYANATES; ISOENZYMES; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 15444377021     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0494826     Document Type: Article

References (34)

1. Höpfl, G.; Ogunshola, O.; Gassmann, M. HIFs and tumors - Causes and consequences. Am. J. Physiol. Regul. Integr. Comput. Physiol. 2004, 286, R608-R623.
2. Pastorekova, S.; Pastorek, J. Cancer-related carbonic anhydrase isozymes and their inhibition. In Carbonic anhydrase - Its inhibitors and activators; Supuran, C. T., Scozzafava, A., Conway, J.; Eds., CRC Press: Boca Raton, FL, 2004; pp 255-282.
3. Supuran, C. T.; Scozzafava, A.; Conway, J., Eds. Carbonic anhydrase - its inhibitors and activators; CRC Press (Taylor and Francis Group): Boca Raton, FL, 2004; pp 1-363, and references therein.
4. (a) Supuran, C. T.; Scozzafava, A. Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin. Ther. Pat. 2000, 10, 575-600;
5. (b) Supuran, C. T.; Scozzafava, A. Applications of carbonic anhydrase inhibitors and activators in therapy. Expert Opin. Ther. Pat. 2002, 12, 217-242;
6. (c) Supuran, C. T.; Scozzafava, A.; Casini, A. Carbonic anhydrase inhibitors. Med. Res. Rev. 2003, 23, 146-189;
7. (d) Scozzafava, A.; Mastrolorenzo, A.; Supuran C. T. Modulation of carbonic anhydrase activity and its applications in therapy. Expert Opin. Ther. Pat. 2004, 14, 667-702.
8. Scozzafava. A.; Owa, T.; Mastrolorenzo, A.; Supuran, C. T. Anticancer and antiviral sulfonamides. Curr. Med. Chem. 2003, 10, 925-953.
9. Winum, J.-Y.; Vullo, D.; Casini, A.; Montero, J.-L.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Inhibition of cytosolic isozymes I and II and the transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors. J. Med. Chem. 2003, 46, 2197-2204.
10. Vullo, D.; Franchi, M.; Gallori, E.; Pastorek, J.; Scozzafava, A.; Pastorekova, S.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with anions. J. Enzyme Inhib. Med. Chem. 2003, 18, 403-406.
11. Winum, J.-Y.; Vullo, D.; Casini, A.; Montero, J.-L.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Inhibition of transmembrane, tumor-associated isozyme IX and cytosolic isozymes I and II with aliphatic sulfamates. J. Med. Chem. 2003, 46, 5471-5477.
12. (a) Weber, A.; Casini, A.; Heine, A.; Kuhn, D.; Supuran, C. T.; Scozzafava, A.; Klebe, G. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2 selective Celecoxib: New pharmacological opportunities due to related binding site recognition. J. Med. Chem. 2004, 47, 550-557.
13. (b) Pastorekova, S.; Casini, A.; Scozzafava, A.; Vullo, D.; Pastorek, J.; Supuran, C. T. Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg. Med. Chem. Lett. 2004, 14, 869-873.
14. (c) Casey, J. R.; Morgan, P. E.; Vullo, D.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX. J. Med. Chem. 2004, 47, 2337-2347.
15. Abbate, F.; Casini, A.; Owa, T.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg. Med. Chem. Lett. 2004, 14, 217-223.
16. Vullo, D.; Franchi, M.; Gallori, E.; Antel, J.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. J. Med. Chem. 2004, 47, 1272-1279.
17. de Leval, X.; Ilies, M.; Casini, A.; Dogné, J.-M.; Scozzafava, A.; Masini, E.; Mincione, F.; Starnotti, M.; Supuran C. T. Carbonic anhydrase inhibitors: Synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity. J. Med. Chem. 2004, 47, 2796-2804.
18. Vullo, D.; Scozzafava, A.; Pastorekova, S.; Pastorek, J.; Supuran, C. T. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered. Bioorg. Med. Chem. Lett. 2004, 14, 2351-2356.
19. Melkko, S.; Scheuermann, J.; Dumelin, C. E.; Neri D. Encoded self-assembling chemical libraries. Nat. Biotechnol. 2004, 22, 568-574.
20. Havlir, D. V.; O'Marro, S. D. Atazanavir: New Option for Treatment of HIV Infection. Clin. Infect. Dis. 2004, 38, 1599-1604.
21. Garg, H. G.; Arora, V. Chemistry and biological activity of N1-acyl-4-arylazopyrazoles. J. Pharm. Sci. 1972, 61, 130-132.
22. Whitehead, C. W.; Traverso, J. J. The reaction of saccharin with amines. N-Substituted-3-amino-1,2-benzisothiazole-1,1-dioxides. J. Org. Chem. 1960, 25, 413-416.
23. Crippa, G. B.; Maffei, S. Derivati solfonamidici del pirazolo. 1-(p-solfonamidofenil)-3-metil-5-pirazolone. Gazz. Chim. Ital. 1941, 71, 97-99.
24. Supuran, C. T.; Casini, A.; Scozzafava, A. Development of sulfonamide carbonic anhydrase inhibitors (CAIs). In Carbonic anhydrase - Its inhibitors and activators; Supuran, C. T., Scozzafava, A., Conway, J.; Eds., CRC Press: Boca Raton, FL, 2004; pp 67-147.
25. Scozzafava, A.; Menabuoni, L.; Mincione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Carbonic anhydrase inhibitors. Perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure lowering agents with prolonged duration of action. J. Med. Chem. 2000, 43, 4542-4551.
26. (a) Supuran, C. T.; Scozzafava, A.; Jurca, B. C.; Ilies, M. A. Carbonic anhydrase inhibitors. Part 49. Synthesis of substituted ureido- and thioureido derivatives of aromatic/heterocyclic sulfonamides with increased affinities for isozyme I. Eur. J. Med. Chem. 1998, 33, 83-93.
27. (b) Casini, A.; Scozzafava, A.; Mincione, F.; Menabuoni, L.; Ilies, M. A.; Supuran, C. T. Carbonic anhydrase inhibitors. Water soluble 4-sulfamoylphenyl-thioureas as topical intraocular pressure lowering agents with long lasting effects. J. Med. Chem. 2000, 43, 4884-4892.
28. (a) Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Arylsulfonylureido and arylureido-substituted aromatic and heterocyclic sulfonamides: towards selective inhibitors of carbonic anhydrase isozyme I. J. Enzyme Inhib. 1999, 14, 343-363.
29. (b) Popescu, A.; Simion, A.; Scozzafava, A.; Briganti, F.; Supuran, C. T. Carbonic anhydrase inhibitors. Schiff bases of some aromatic sulfonamides and their metal complexes: towards more selective inhibitors of carbonic anhydrase isozyme IV. J. Enzyme Inhib. 1999, 14, 407-423.
30. (a) Abbate, F.; Casini, A.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the perfluorobenzoyl analogue of methazolamide. Implications for the drug design of fluorinated inhibitors. J. Enzyme Inhib. Med. Chem. 2003, 18, 303-308.
31. (b) Casini, A.; Abbate, F.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a bis-sulfonamide - two heads are better than one? Bioorg. Med. Chem. Lett. 2003, 13, 2759-2763.
32. (c) Abbate, F.; Casini, A.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide. Bioorg. Med. Chem. Lett. 2004, 14, 2357-2361.
33. Supuran, C. T. Indisulam: an anticancer sulfonamide in clinical development. Expert Opin. Investig. Drugs 2003, 12, 283-287.
34. Pastorek, J.; Pastorekova, S.; Callebaut, I.; Mornon, J. P.; Zelnik, V.; Opavsky, R.; Zatovicova, M.; Liao, S.; Portetelle, D.; Stanbridge, E. J.; Zavada, J.; Burny, A.; Kettmann, R. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase an a putative helix-loop-helix DNA binding segment. Oncogene 1994, 9, 2877-2888.